120. The clinical and operative impact of lumbar epidural steroid injections prior to spine surgery for lumbar spinal stenosis

Abstract

<h3>BACKGROUND CONTEXT</h3> Lumbar spinal stenosis is a common finding in the adult population. Lumbar epidural steroid injections (ESIs) are often used in management of this condition, with conflicting evidence regarding their efficacy. Previous research has suggested a negative impact of ESIs on the operative times and postoperative outcomes when ESIs are administered preoperatively prior to spine surgery in this population. Our retrospective study was performed to gain greater insight into the impact of preoperative ESIs on postoperative outcomes following spine surgery in management of lumbar stenosis. <h3>PURPOSE</h3> Our objective is to determine how preoperative ESIs impact postoperative outcomes following spine surgery in management of lumbar stenosis. <h3>STUDY DESIGN/SETTING</h3> Retrospective cohort involving patients who underwent surgical management of lumbar stenosis. Data for patients with preoperative ESI was compared to those without preoperative ESI administration. <h3>PATIENT SAMPLE</h3> Patient data for this retrospective cohort was retrieved solely from a patient database of a medical institution in north Texas, US. Patients were included in the study if they underwent surgical management of lumbar spinal stenosis between January 2016 and December 2020. The inclusion criteria required an active diagnosis of lumbar spinal stenosis. Patients who received an ESI within three months prior to the spine surgery were included in the "ESI" group, while those who did not receive a lumbar ESI within three months prior to the spine surgery were included in the "Non-ESI" group. <h3>OUTCOME MEASURES</h3> Primary outcome measures were ODI (Oswestry Disability Index) back, NDI (Neck Disability Index) back, VAS (Visual Analog Scale) leg pain, VAS back pain, PROMIS (Patient-Reported Outcomes Measurement Information System) pain, PROMIS pain interference, PROMIS satisfaction, PROMIS physical function at time of spine surgery (baseline) and at three months after surgery. <h3>METHODS</h3> This study was conducted at a medical institution in north Texas, US, utilizing the institution's spine center database. The institutional review board approved the standardized protocol. This study included a retrospective cohort. All results were collated on a Microsoft Excel file as retrieved from a patient registry of a medical institution in north Texas based on exclusion and inclusion criteria above. Statistical analysis was performed using IBM SPSS software, with t-test and ANOVA used to determine significance. P-value less than 0.05 was considered statistically significant. <h3>RESULTS</h3> Patients receiving an ESI in the preoperative period had shorter operative times (ESI 157 minutes vs Non-ESI 187 minutes, p=.10) during spine surgery than did patients in the Non-ESI group. Both ESI and Non-ESI groups showed significant improvements in VAS leg, VAS back, ODI and PROMIS pain scores at three months after surgery, with the ESI group showing a significantly larger improvement compared to the Non-ESI group in PROMIS pain scores. <h3>CONCLUSIONS</h3> Regardless of preoperative ESI administration, this study demonstrated improvement in pain and disability scores in the postoperative period following surgical management of lumbar stenosis. Patients who received ESI in the preoperative course had shorter operative times and greater improvements in PROMIS pain scores in the postoperative course compared to those who did not receive ESI. <h3>FDA DEVICE/DRUG STATUS</h3> This abstract does not discuss or include any applicable devices or drugs.